1. Chronic renal insufficiency
The researchers found that Bailing Capsules and Jinshuibao Capsules can improve malnutrition in patients with chronic renal insufficiency, significantly improve clinical indicators such as glomerulonephritis and urine protein, and delay chronic renal insufficiency. Bailing Capsules can also improve the vascular endothelial function of patients and reduce the incidence of atherosclerosis; Jinshuibao Capsules can improve the micro-inflammation state and renal anemia in patients with chronic renal insufficiency, and its curative effect is better than that of western medicine, with less side effects; Xinganbao Capsules Combined with other drugs, it has a certain curative effect on chronic renal failure, can significantly reduce urinary protein in the kidney, and has a protective effect on the kidney.
2. Early diabetic nephropathy
In order to explore the clinical curative effect of Bailing Capsules and Jinshuibao Capsules on early diabetic nephropathy, the researchers compared the treatment group (taking Bailing Capsules or Jinshuibao Capsules) and the control group, and found that the urinary protein excretion rate and serum creatinine level of the patients in the treatment group Compared with the control group, there is a significant difference. It has a good therapeutic effect on early diabetic nephropathy and is worthy of popularization and application in clinic.
3. Chronic Obstructive Pulmonary Disease (COPD)
Bailing Capsules can improve the lung function of COPD patients, reduce serum TNF-α level, increase FEV1, FEV1% predicted value, FEV1/FVC; can significantly reduce MDA, increase serum SOD, NO, thus effectively improving the imbalance of oxidation/antioxidation in COPD patients. Bailing Capsule is suitable for patients in the stable stage, which can improve the immune ability of the patient’s body and prevent the acute attack of COPD; it is also suitable for patients in the acute exacerbation stage of COPD, it can improve the Scr, BUN, GFR, and 24h urine output of the patient, Significantly shorten the total time of oliguria, the duration of oliguria and the time for urine protein to return to normal, thereby improving the quality of life of patients. Jinshuibao Capsules can significantly reduce the levels of TNF-α and TGF-β1 in patients with chronic obstructive pulmonary disease, reduce inflammatory reactions, affect the remodeling of airways in patients, relieve airflow limitation, and improve clinical curative effect. Immunoglobulin IgG, IgA, C3, C50, significantly improved lung function.
4. Other clinical applications
Cordyceps Sinensis Powder is used in clinical application to suppress renal transplant rejection by reducing rejection, and is an ideal immunosuppressant for organ transplantation. By observing patients with essential hypertension clinically, the researchers found that Bailing Capsules can reduce blood UA and TG levels, increase HDL-C levels, improve clinical related indicators, and have obvious therapeutic effects; it is reported that Bailing Capsules also use It is used in the treatment of non-liquefied semen, urethral syndrome in middle-aged and elderly women, and autoimmune thyroid disease. According to reports, Jinshuibao Capsules are used in the perioperative period of BPH, which can improve the function of the heart, lung, brain and other important organs of BPH patients, reduce the risk of surgery, prevent and reduce the occurrence of complications, and accelerate the postoperative recovery of patients; Cerebral infarction and asthma also have therapeutic effect. Jinshuibao Capsules combined with Valsartan can treat diabetic nephropathy complicated with erectile dysfunction, combined with Huangjing Zanyu Capsules (extracted and refined from traditional Chinese medicines such as Polygonum multiflorum, Polygonatum Polygonum, Lycium barbarum, Patrinia, etc.) to treat kidney deficiency, essence deficiency and damp-heat syndrome type asthenosperm Male infertility caused by spermatozoa and oligospermia. Xinganbao Capsule also has the effect of reducing liver damage and promoting serum normalization, especially can reduce the level of serum liver fibrosis index, so as to reduce and inhibit the formation of liver fibrosis; it can improve chronic ischemic hypoxic pulmonary heart disease Symptoms of the disease, reduce the recurrence rate, and reduce the side effects of drugs. Ningxinbao capsule can increase the heart rate of slow-type arrhythmia in organic heart disease and reduce the probability of acute myocardial infarction. It is a safe and effective antiarrhythmic drug.